ATE307586T1 - Hemmung von mit gewebetrauma verbundenen pathogenen prozessen - Google Patents

Hemmung von mit gewebetrauma verbundenen pathogenen prozessen

Info

Publication number
ATE307586T1
ATE307586T1 AT99936952T AT99936952T ATE307586T1 AT E307586 T1 ATE307586 T1 AT E307586T1 AT 99936952 T AT99936952 T AT 99936952T AT 99936952 T AT99936952 T AT 99936952T AT E307586 T1 ATE307586 T1 AT E307586T1
Authority
AT
Austria
Prior art keywords
group
effector
pharmaceutically acceptable
tissue trauma
hydrogen
Prior art date
Application number
AT99936952T
Other languages
German (de)
English (en)
Inventor
Mark Pines
Israel Vlodavsky
Arnon Nagler
Eli Hazum
Original Assignee
Hadasit Med Res Service
Agricultural Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service, Agricultural Res Org filed Critical Hadasit Med Res Service
Application granted granted Critical
Publication of ATE307586T1 publication Critical patent/ATE307586T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99936952T 1998-08-13 1999-08-13 Hemmung von mit gewebetrauma verbundenen pathogenen prozessen ATE307586T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12579098 1998-08-13
US13714599P 1999-06-01 1999-06-01
PCT/IL1999/000440 WO2000009070A2 (en) 1998-08-13 1999-08-13 Inhibition of pathogenic processes related to tissue trauma

Publications (1)

Publication Number Publication Date
ATE307586T1 true ATE307586T1 (de) 2005-11-15

Family

ID=26323693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936952T ATE307586T1 (de) 1998-08-13 1999-08-13 Hemmung von mit gewebetrauma verbundenen pathogenen prozessen

Country Status (8)

Country Link
EP (1) EP1109559B1 (enExample)
JP (1) JP2002522462A (enExample)
AT (1) ATE307586T1 (enExample)
AU (1) AU756437B2 (enExample)
CA (1) CA2340176A1 (enExample)
DE (1) DE69927987T2 (enExample)
ES (1) ES2255286T3 (enExample)
WO (1) WO2000009070A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143366A0 (en) * 2001-05-24 2002-04-21 Harasit Medical Res Services & Treatment of renal fibrosis
EP1558261A4 (en) * 2002-10-31 2008-06-04 Israel State CHINAZOLINONE COMPOSITIONS TO REGULATE GENE EXPRESSION IN CONNECTION WITH PATHOLOGICAL PROCESSES
RU2243778C2 (ru) * 2003-02-18 2005-01-10 Московский городской научно-исследовательский институт скорой помощи им. Н.В. Склифосовского Способ лечения последствий травматического и интраоперационного повреждения тканей у больных с политравмой
WO2007120606A2 (en) 2006-04-10 2007-10-25 President And Fellows Of Harvard College Methods for modulating formation and progression of cellulite
CA2711743C (en) 2007-01-21 2015-04-07 Agricultural Research Organization Quinazolinone derivatives for treating or preventing skeletal muscle fibrosis
CA2737219C (en) 2008-08-11 2017-02-28 Tracy Keller Halofuginone analogs for inhibition of trna synthetases and uses thereof
WO2012108538A1 (ja) 2011-02-10 2012-08-16 国立大学法人 長崎大学 急性肺損傷診断方法
AU2013207796B2 (en) 2012-01-13 2017-04-27 President And Fellows Of Harvard College Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
US11708353B2 (en) 2018-06-08 2023-07-25 The General Hospital Corporation Inhibitors of prolyl-tRNA-synthetase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
JPH08510251A (ja) * 1993-05-07 1996-10-29 ビー マーゴリン、ソロモン 線維症の病変の修復と予防のための組成物および方法
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
JPH0971586A (ja) * 1995-09-07 1997-03-18 Yamanouchi Pharmaceut Co Ltd 新規な二環性縮合イミダゾール誘導体
AU3667397A (en) * 1996-07-03 1998-01-21 Alain Colige Recombinant n-proteinase, and the production, methods and uses thereof
PT930876E (pt) * 1996-07-22 2005-01-31 Renovo Ltd Utilizacao de moduladores da funcao esteroide sexual para tratar feridas e desordens fibroticas
EP0941108B1 (en) * 1996-12-04 2002-10-16 Renovo Limited Wound healing and treatment of fibrosis
US5852024A (en) * 1997-02-11 1998-12-22 Hadasit Treatment and prevention of adhesions
US6028075A (en) * 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
DE19951702A1 (de) * 1999-10-27 2001-05-03 Aventis Pharma Gmbh Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten

Also Published As

Publication number Publication date
AU756437B2 (en) 2003-01-16
WO2000009070A3 (en) 2000-10-19
EP1109559A4 (en) 2002-05-08
CA2340176A1 (en) 2000-02-24
EP1109559A2 (en) 2001-06-27
WO2000009070A2 (en) 2000-02-24
ES2255286T3 (es) 2006-06-16
EP1109559B1 (en) 2005-10-26
AU5191499A (en) 2000-03-06
JP2002522462A (ja) 2002-07-23
DE69927987T2 (de) 2006-11-09
DE69927987D1 (de) 2005-12-01

Similar Documents

Publication Publication Date Title
BR0317435A (pt) Derivados de pirimidina para o tratamento do crescimento celular anormal
WO2001019798A3 (en) Inhibitors of factor xa
DK0682664T3 (da) Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler
MY135841A (en) Novel benzodioxoles
TW369526B (en) Diazabicyclic neurokinin antagonists
BRPI0409417A (pt) método para usar um composto, composto, e, composição
BR0008202A (pt) Derivados de quinolin-2-ona substituìdos com heteroarilas úteis como agentes contra o câncer
ATE191143T1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
DE69724811D1 (de) Pentafluorobenzensulfonamide und analoge
BR9811099A (pt) Inibidores de urocinase
NO304891B1 (no) Steroidderivater for behandling av prostatahypertrofi
DE60141520D1 (de) 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
ATE307586T1 (de) Hemmung von mit gewebetrauma verbundenen pathogenen prozessen
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
NZ506497A (en) Indole derivatives, pharmaceuticals thereof and their use in lowering intraocular pressure or for the treatment or prevention of glaucoma or ocular hypertension
DE69808099D1 (de) Substituierte 6-alkylphenanthridine
NO20010654D0 (no) Ny anvendelse av taxoidderivater
CR7931A (es) 4-[(2,4-dicloro-5-metroxifenil)amino]-6-alkoxi-3- quinolincarbonitrilos para el tratamiento de lesiones isquemicas
KR970702273A (ko) 인돌 유도체 및 이를 함유하는 제제(indole derivative and medicine containing the same)
DE69232143D1 (de) Verwendung von Amlexanox zur Herstellung eines Arzneimittels zur Behandlung von aphtösen Ulcera
EP1418910A4 (en) METHODS FOR INHIBITING OR REVERTING THE PROCESS OF FORMING TURF OR POLYMERIZATION FILAMENTS
ES2099180T3 (es) Derivados del benzopirano y procedimientos para su preparacion.
DK0912568T3 (da) Imidazopyridiner

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties